US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Incyte

123.22

-1.1500-0.92%

Pre-market: 123.250.0300+0.02%04:00 EDT

Volume:1.48M

Turnover:182.70M

Market Cap:24.98B

PE:15.70

High:124.00

Open:122.66

Low:121.61

Close:124.37

52wk High:132.60

52wk Low:81.09

Shares:202.70M

Float Shares:169.82M

Volume Ratio:1.59

T/O Rate:0.87%

Dividend:- -

Dividend Rate:- -

EPS(TTM):7.85

EPS(LYR):6.41

ROE:30.67%

ROA:16.83%

PB:3.94

PE(LYR):19.22

Loading ...

Overview Company News Filings

Incyte Japan wins approval for Minjuvi-lenalidomide in relapsed or refractory DLBCL

Incyte Japan Announces Approval of Minjuvi® (Tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl)

THOMSON REUTERS

Incyte : Jefferies Raises Target Price to $100 From $94

THOMSON REUTERS

Incyte (INCY) Stock Could Be 8.1% Undervalued After FDA Priority Review And Trial Results

Simply Wall St.

Incyte Corp. Stock Slips 6.0%, Underperforms Peers

Movement Alert｜Incyte Declines 5.37% in Regular Trading, Trading at $104.11

Salveen Richter Reiterates Hold on Incyte as Mid‑Stage INCA033989 Data Align with Expectations Amid Rising Myelofibrosis Competition

Incyte: Buy Rating Reaffirmed on Promising INCA033989 Data and Risk-Reward, $124 Price Target Unchanged

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)

Matt Phipps Reiterates Hold on Incyte as Encouraging INCA033989 Data Offset by Efficacy Moderation and Phase III Execution Risks

Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial

MT Newswires Live

Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study

Incyte announces clinical data from two Phase 2 studies of INCA033989

Incyte announces results from Phase 3 frontMIND trial of tafasitamab

Mirum, Incyte report pivotal Phase 2 PROGRESS data showing zilurgisertib cuts new FOP bone lesion volume 99.9% at Week 24

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results From Progress Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Incyte says mutant CALR antibody INCA033989 delivers sustained responses in Phase 1 myelofibrosis, essential thrombocythemia studies

Incyte Announces New Positive Data at Eha 2026 Showed Inca033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients With Myelofibrosis and Essential Thrombocythemia

THOMSON REUTERS

Incyte says Phase 3 frontMIND trial shows tafasitamab combo cuts lymphoma progression or death risk 25%

Results From Incyte’s Pivotal Phase 3 Frontmind Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (Eha) Congress Plenary Showed Prolonged Progression Free Survival

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/INCY/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"Incyte","latestPrice":123.22,"timestamp":1788206400000,"preClose":124.37,"halted":0,"volume":1483195,"hourTrading":{"tag":"盘前","latestPrice":123.25,"preClose":123.22,"latestTime":"04:00 EDT","volume":25,"amount":3081.25,"timestamp":1788249618763,"change":0.03,"changeRate":0.000243,"amplitude":0},"delay":0,"changeRate":-0.009246602878507724,"floatShares":169819727,"shares":202697746,"eps":7.85,"marketStatus":"Pre-Mkt","change":-1.15,"latestTime":"09-01 04:38:15 EDT","open":122.66,"high":124,"low":121.61,"amount":182701977.2452,"amplitude":0.019217,"askPrice":134.26,"askSize":24,"bidPrice":108.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":7.85,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":123.22,"preHourTrading":{"tag":"盘前","latestPrice":123.25,"preClose":123.22,"latestTime":"04:00 EDT","volume":25,"amount":3081.25,"timestamp":1788249618763,"change":0.03,"changeRate":0.000243,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":123.4131,"preClose":123.22,"latestTime":"19:30 EDT","volume":217273,"amount":26773423.288624,"timestamp":1788219001706,"change":0.1931,"changeRate":0.001567,"amplitude":0.00159},"volumeRatio":1.5853281825301073,"impliedVol":0.35,"impliedVolPercentile":0.3267},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":169819727,"roa":"16.83%","roe":"30.67%","lyrEps":6.41,"volumeRatio":1.5853281825301073,"shares":202697746,"dividePrice":0,"high":124,"amplitude":0.019217,"preClose":124.37,"low":121.61,"week52Low":81.09,"pbRate":"3.94","psRate":"4.29","week52High":132.6,"institutionHeld":0.9196,"latestPrice":123.22,"committee":0.612903,"eps":7.85,"divideRate":0,"volume":1483195,"delay":0,"ttmEps":7.85,"open":122.66,"prevYearClose":98.77,"prevWeekClose":124.37,"prevMonthClose":119.52,"prevQuarterClose":113.36,"fiveDayClose":127.98,"twentyDayClose":118.43,"sixtyDayClose":101.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"INCY","fiscalQuarterEnding":"2026/06","expectedEps":1.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":2.8},{"market":"US","date":"2026-04-28","symbol":"INCY","fiscalQuarterEnding":"2026/03","expectedEps":1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777348800000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2026-02-10","symbol":"INCY","fiscalQuarterEnding":"2025/12","expectedEps":1.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2025-10-28","symbol":"INCY","fiscalQuarterEnding":"2025/09","expectedEps":1.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":2.03},{"market":"US","date":"2025-07-29","symbol":"INCY","fiscalQuarterEnding":"2025/06","expectedEps":1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"pre","actualEps":1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2069,"buy":0.2414,"hold":0.5517,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2414,"analysts":29,"updateTime":1787457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2026-08-28","current":15.696815,"percent":0.12969,"low":12.870654,"twenty":16.844049,"median":22.291093,"eighty":53.112386,"high":648.145308,"avg":97.626065,"sd":164.593708,"marketCap":25892610074},"quantilePoints":[{"date":"2021-09-03","current":49.767371,"twenty":-126.920152,"median":-53.75838,"eighty":132.851508,"marketCap":16803355618},{"date":"2021-09-10","current":46.516696,"twenty":-126.920152,"median":-53.75838,"eighty":131.356968,"marketCap":15705804331},{"date":"2021-09-17","current":49.701965,"twenty":-126.920152,"median":-53.75838,"eighty":73.50992,"marketCap":16781272091},{"date":"2021-09-24","current":45.130091,"twenty":-126.920152,"median":-53.75838,"eighty":72.160274,"marketCap":15237633561},{"date":"2021-10-01","current":44.613384,"twenty":-126.920152,"median":-53.75838,"eighty":71.599051,"marketCap":15063173698},{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-25","current":349.904367,"twenty":-53.209696,"median":27.168166,"eighty":48.304069,"marketCap":11412130919},{"date":"2025-05-02","current":564.51072,"twenty":-53.209696,"median":27.168166,"eighty":48.393956,"marketCap":12007143006},{"date":"2025-05-09","current":543.579321,"twenty":-52.564683,"median":27.496923,"eighty":48.460691,"marketCap":11561932157},{"date":"2025-05-16","current":571.154163,"twenty":15.632391,"median":27.625789,"eighty":48.737881,"marketCap":12148449057},{"date":"2025-05-23","current":587.080228,"twenty":15.726225,"median":27.883789,"eighty":49.007354,"marketCap":12487196442},{"date":"2025-05-30","current":601.004158,"twenty":15.826258,"median":28.029696,"eighty":49.252879,"marketCap":12783358441},{"date":"2025-06-06","current":611.924888,"twenty":15.885314,"median":28.339221,"eighty":49.434802,"marketCap":13015642362},{"date":"2025-06-13","current":629.944092,"twenty":15.934986,"median":28.478966,"eighty":49.660105,"marketCap":13398910831},{"date":"2025-06-20","current":621.298514,"twenty":15.990815,"median":28.671445,"eighty":49.822312,"marketCap":13215019394},{"date":"2025-06-27","current":644.414059,"twenty":16.096118,"median":28.856014,"eighty":50.382952,"marketCap":13706687026},{"date":"2025-07-03","current":622.936624,"twenty":16.116941,"median":28.993122,"eighty":50.591002,"marketCap":13249861982},{"date":"2025-07-11","current":640.136773,"twenty":16.200713,"median":29.581278,"eighty":51.047771,"marketCap":13615709157},{"date":"2025-07-18","current":627.395921,"twenty":16.252966,"median":30.035802,"eighty":51.822721,"marketCap":13344711249},{"date":"2025-07-25","current":641.501864,"twenty":16.33326,"median":30.242404,"eighty":52.761862,"marketCap":13644744647},{"date":"2025-08-01","current":16.792668,"twenty":16.378635,"median":30.24819,"eighty":52.992543,"marketCap":14624230499},{"date":"2025-08-08","current":17.534873,"twenty":16.546711,"median":30.24819,"eighty":52.992543,"marketCap":15270594539},{"date":"2025-08-15","current":19.319752,"twenty":16.607924,"median":30.24819,"eighty":52.992543,"marketCap":16824992653},{"date":"2025-08-22","current":19.402718,"twenty":16.798469,"median":30.24819,"eighty":52.992543,"marketCap":16897244826},{"date":"2025-08-29","current":18.768144,"twenty":16.870655,"median":30.24819,"eighty":52.992543,"marketCap":16344613336},{"date":"2025-09-05","current":19.158306,"twenty":16.99751,"median":30.268023,"eighty":53.052464,"marketCap":16684393828},{"date":"2025-09-12","current":19.321995,"twenty":17.085907,"median":30.24819,"eighty":52.992543,"marketCap":16826945414},{"date":"2025-09-19","current":19.283875,"twenty":17.161262,"median":30.24819,"eighty":52.992543,"marketCap":16793748470},{"date":"2025-09-26","current":18.310712,"twenty":17.193493,"median":30.24819,"eighty":52.992543,"marketCap":15946250000},{"date":"2025-10-03","current":19.34666,"twenty":17.274387,"median":30.24819,"eighty":52.992543,"marketCap":16848425790},{"date":"2025-10-10","current":19.003586,"twenty":17.291711,"median":30.24819,"eighty":52.992543,"marketCap":16549653288},{"date":"2025-10-17","current":19.577618,"twenty":17.328736,"median":30.24819,"eighty":52.992543,"marketCap":17049560219},{"date":"2025-10-24","current":20.02608,"twenty":17.356711,"median":30.24819,"eighty":52.992543,"marketCap":17440112509},{"date":"2025-10-31","current":15.211911,"twenty":17.362586,"median":30.24819,"eighty":52.992543,"marketCap":18080618265},{"date":"2025-11-07","current":17.376278,"twenty":17.372241,"median":30.24819,"eighty":52.992543,"marketCap":20653148355},{"date":"2025-11-14","current":17.410964,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":20694376123},{"date":"2025-11-21","current":16.80808,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":19977798257},{"date":"2025-11-28","current":17.254049,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":20507869555},{"date":"2025-12-05","current":16.593354,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19722578743},{"date":"2025-12-12","current":15.873197,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":18866611758},{"date":"2025-12-19","current":16.073057,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19104162228},{"date":"2025-12-26","current":16.590051,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19718652289},{"date":"2026-01-02","current":16.314211,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19390793375},{"date":"2026-01-09","current":17.495203,"twenty":17.426189,"median":30.24819,"eighty":52.992543,"marketCap":20794500701},{"date":"2026-01-16","current":17.382885,"twenty":17.442549,"median":30.24819,"eighty":52.992543,"marketCap":20661001263},{"date":"2026-01-23","current":17.353153,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20625663177},{"date":"2026-01-30","current":16.695762,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":19844298819},{"date":"2026-02-06","current":16.973254,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20174120960},{"date":"2026-02-13","current":15.583655,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20050709464},{"date":"2026-02-20","current":15.735238,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20245743660},{"date":"2026-02-27","current":15.481568,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19919359903},{"date":"2026-03-06","current":15.054661,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19370079922},{"date":"2026-03-13","current":14.234876,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18315303146},{"date":"2026-03-20","current":14.377178,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18498396473},{"date":"2026-03-27","current":14.270452,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18361076478},{"date":"2026-04-02","current":14.585992,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18767066029},{"date":"2026-04-10","current":14.997431,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19296444562},{"date":"2026-04-17","current":14.743762,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18970060805},{"date":"2026-04-24","current":14.766963,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18999912978},{"date":"2026-05-01","current":13.293443,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19033245906},{"date":"2026-05-08","current":13.642279,"twenty":17.433127,"median":30.118443,"eighty":52.992543,"marketCap":19532701294},{"date":"2026-05-15","current":13.622744,"twenty":17.411313,"median":29.746559,"eighty":52.992543,"marketCap":19504731792},{"date":"2026-05-22","current":13.592047,"twenty":17.387328,"median":29.09859,"eighty":52.992543,"marketCap":19460779718},{"date":"2026-05-29","current":13.604605,"twenty":17.36462,"median":28.916658,"eighty":53.052464,"marketCap":19478760112},{"date":"2026-06-05","current":14.126463,"twenty":17.348937,"median":28.776913,"eighty":52.992543,"marketCap":20225945372},{"date":"2026-06-12","current":15.045995,"twenty":17.325325,"median":28.50797,"eighty":52.992543,"marketCap":21542509773},{"date":"2026-06-18","current":13.812511,"twenty":17.289424,"median":28.436682,"eighty":52.992543,"marketCap":19776435523},{"date":"2026-06-26","current":15.004135,"twenty":17.272525,"median":28.112465,"eighty":53.052464,"marketCap":21482575127},{"date":"2026-07-02","current":15.880411,"twenty":17.240692,"median":27.997224,"eighty":53.052464,"marketCap":22737207060},{"date":"2026-07-10","current":16.537618,"twenty":17.19048,"median":27.743327,"eighty":53.052464,"marketCap":23678181010},{"date":"2026-07-17","current":16.276689,"twenty":17.163644,"median":27.552445,"eighty":53.052464,"marketCap":23304588380},{"date":"2026-07-24","current":16.28227,"twenty":17.105678,"median":27.323117,"eighty":53.052464,"marketCap":23312579666},{"date":"2026-07-31","current":15.46146,"twenty":17.048056,"median":27.019412,"eighty":53.112386,"marketCap":24929795780},{"date":"2026-08-07","current":14.881923,"twenty":16.977387,"median":26.862395,"eighty":53.112386,"marketCap":23995359171},{"date":"2026-08-14","current":15.150949,"twenty":16.947387,"median":26.172344,"eighty":53.112386,"marketCap":24429132347},{"date":"2026-08-21","current":15.993227,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"marketCap":25787207246},{"date":"2026-08-28","current":16.058598,"twenty":16.844049,"median":22.291093,"eighty":53.112386,"marketCap":25892610074}],"updateTime":1788237286823},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644053486","title":"Incyte Japan wins approval for Minjuvi-lenalidomide in relapsed or refractory DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2644053486","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644053486?lang=en_us&edition=fundamental","pubTime":"2026-06-19 14:00","pubTimestamp":1781848841,"startTime":"0","endTime":"0","summary":"Incyte won Japan MHLW clearance for Minjuvi  with lenalidomide in adults with relapsed or refractory DLBCL.Decision targets patients ineligible for autologous stem cell transplant.L-MIND showed 58.8% ORR, including 41.3% complete responses; J-MIND showed 71.4% ORR, including 45.2% complete responses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire  on June 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nNDL5MYMqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","INCY","BK4585","BK4139","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644053944","title":"Incyte Japan Announces Approval of Minjuvi® (Tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644053944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644053944?lang=en_us&edition=fundamental","pubTime":"2026-06-19 14:00","pubTimestamp":1781848801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nTUA4CRJXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4532","INCY","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644744434","title":"Incyte : Jefferies Raises Target Price to $100 From $94","url":"https://stock-news.laohu8.com/highlight/detail?id=2644744434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644744434?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:21","pubTimestamp":1781706102,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4588","BK4550","INCY","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644990748","title":"Incyte (INCY) Stock Could Be 8.1% Undervalued After FDA Priority Review And Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2644990748","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644990748?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:41","pubTimestamp":1781692884,"startTime":"0","endTime":"0","summary":"Recent interest in Incyte (INCY) stock is closely tied to fresh clinical and regulatory milestones, including pivotal data for zilurgisertib in fibrodysplasia ossificans progressiva and Phase 3 results for tafasitamab plus lenalidomide with R-CHOP.\nSee our latest analysis for Incyte.\nIncyte stock has cooled slightly in the very short term, with a 1-day share price return of 2.19% and a 7-day share price return of 5.35%. However, the 1-year total shareholder return of 46.11% and 3-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-81-undervalued-after-fda-priority","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-81-undervalued-after-fda-priority","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","INCY","BK4532","DCF","BK4585","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643786820","title":"Incyte Corp. Stock Slips 6.0%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2643786820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643786820?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:34","pubTimestamp":1781555640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Incyte Corp. slid 6.0% to $101.98 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.7% to 7,554.29 and the Dow Jones Industrial Average rising 0.9% to 51,671.03.The stock's fall snapped a four-day winning streak.Incyte Corp. closed 9.2% below its 52-week high of $112.29, which the company reached on January 7th.The stock underperformed when compared to some of its peers, as Alnylam Pharmaceuticals Inc. rose 1.8% to $287.80, Bio-Techne Corp. rose 4.0% to $56.17, and BioMarin Pharmaceutical Inc. fell 0.54% to $55.65.Trading volume totaled 2.8 million, compared to the 50-day average of 1.5 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168018671","title":"Movement Alert｜Incyte Declines 5.37% in Regular Trading, Trading at $104.11","url":"https://stock-news.laohu8.com/highlight/detail?id=1168018671","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168018671?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:04","pubTimestamp":1781535878,"startTime":"0","endTime":"0","summary":"On June 15, Incyte declined 5.37% in regular trading, trading at $104.11/share, with Turnover of $64.25 million.Within the Biotechnology sector where Incyte belongs, the overall sector performance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203209","title":"Salveen Richter Reiterates Hold on Incyte as Mid‑Stage INCA033989 Data Align with Expectations Amid Rising Myelofibrosis Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:45","pubTimestamp":1781531134,"startTime":"0","endTime":"0","summary":"Incyte, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Salveen Richter from Goldman Sachs maintained a Hold r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/salveen-richter-reiterates-hold-on-incyte-as-midstage-inca033989-data-align-with-expectations-amid-rising-myelofibrosis-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/salveen-richter-reiterates-hold-on-incyte-as-midstage-inca033989-data-align-with-expectations-amid-rising-myelofibrosis-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","LU2471134879.HKD","LU1894683264.USD","BK4588","LU1868836591.USD","LU0868494617.USD","LU0048573561.USD","BK4139","LU2471134523.USD","LU0345770308.USD","LU0061475181.USD","BK4533","LU0742534661.SGD","LU2265009873.SGD","XLV","BK4550","BK4581","LU0251131958.USD","LU1868836757.USD","IE00B19Z3581.USD","BK4516","BK4532","LU1791807156.HKD","LU2237443549.SGD","LU0942090050.USD","LU2237443622.USD","LU1868836914.USD","IE00BFXG1179.USD","LU0868494708.USD","LABU","LU1868837300.USD","LU2471134796.USD","LU2471134952.CNY","XBI","LU2237443895.HKD","IE0004091025.USD","LU2237443978.SGD","LU2750360997.AUD","IE0002270589.USD","GSX","LU0345770993.USD","LU1804176565.USD","IE0034235188.USD","BK4504","LU0096364046.USD","LU1668664300.SGD","LU0106831901.USD","LU2237438978.USD","IE00B19Z3B42.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208923","title":"Incyte: Buy Rating Reaffirmed on Promising INCA033989 Data and Risk-Reward, $124 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208923?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:35","pubTimestamp":1781523322,"startTime":"0","endTime":"0","summary":"Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Incyte. The associated price target remains the same with $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incyte-buy-rating-reaffirmed-on-promising-inca033989-data-and-risk-reward-124-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incyte-buy-rating-reaffirmed-on-promising-inca033989-data-and-risk-reward-124-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643127086","title":"Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643127086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643127086?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:50","pubTimestamp":1781520645,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-incyte-incy-intellia-therapeutics-ntla-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-incyte-incy-intellia-therapeutics-ntla-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA","LU1861559042.SGD","XBI","INCY","BK4535","HCSG","LU0128526141.USD","BK4585","BK4137","BK4550","LABU","BK4588","BK4556","LU1861558580.USD","XLV","LU0029874061.USD","HALO","BK4532","BK4139","BK4581","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643274777","title":"Matt Phipps Reiterates Hold on Incyte as Encouraging INCA033989 Data Offset by Efficacy Moderation and Phase III Execution Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2643274777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643274777?lang=en_us&edition=fundamental","pubTime":"2026-06-15 17:48","pubTimestamp":1781516930,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their neutral stance on INCY stock, giving a Hold rating on June 9. Matt Phipps has given his Hold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-reiterates-hold-on-incyte-as-encouraging-inca033989-data-offset-by-efficacy-moderation-and-phase-iii-execution-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-reiterates-hold-on-incyte-as-encouraging-inca033989-data-offset-by-efficacy-moderation-and-phase-iii-execution-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4585","INCY","III","BK4550","BK4532","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643275959","title":"Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643275959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643275959?lang=en_us&edition=fundamental","pubTime":"2026-06-15 16:00","pubTimestamp":1781510444,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals  and Incyte  said Sunday their threapeutic candidate for fibrodysplasia ossificans progressiva, zilurgisertib, demonstrated positive results during a phase 2 study.The product showed meaningful reductions in total heterotopic ossification, or HO, lesion volume and no new HO lesions and flare activity in adolescents and adults with fibrodysplasia ossificans progressiva.The companies said the US Food and Drug Administration has accepted the new drug application and granted priority review for zilurgisertib as a treatment for fibrodysplasia ossificans progressiva in patients 12 years and older.The Prescription Drug User Fee Act target date for the product is Sept. 26, according to the companies.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4585","INCY","BK4588","MIRM","BK4550","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643333240","title":"Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study","url":"https://stock-news.laohu8.com/highlight/detail?id=2643333240","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643333240?lang=en_us&edition=fundamental","pubTime":"2026-06-15 05:20","pubTimestamp":1781472007,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals (MIRM) and Incyte (INCY) announced Phase 2 results from Cohort 1 of the Progress study evaluating zilurgisertib, an investiga...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-mirum-announces-phase-2-results-from-cohort-1-of-progress-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-mirum-announces-phase-2-results-from-cohort-1-of-progress-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","BK4588","BK4550","BK4139","MIRM","PRGS","BK4097","BK4585","LU2065732104.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643247046","title":"Incyte announces clinical data from two Phase 2 studies of INCA033989","url":"https://stock-news.laohu8.com/highlight/detail?id=2643247046","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643247046?lang=en_us&edition=fundamental","pubTime":"2026-06-15 05:15","pubTimestamp":1781471733,"startTime":"0","endTime":"0","summary":"Incyte (INCY) announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-announces-clinical-data-from-two-phase-2-studies-of-inca033989-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-announces-clinical-data-from-two-phase-2-studies-of-inca033989-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","INCY","BK4139","BK4550","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643028247","title":"Incyte announces results from Phase 3 frontMIND trial of tafasitamab","url":"https://stock-news.laohu8.com/highlight/detail?id=2643028247","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643028247?lang=en_us&edition=fundamental","pubTime":"2026-06-15 05:10","pubTimestamp":1781471435,"startTime":"0","endTime":"0","summary":"Incyte (INCY) announced positive results from the Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab, a humanized Fc-modifie...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-announces-results-from-phase-3-frontmind-trial-of-tafasitamab-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-announces-results-from-phase-3-frontmind-trial-of-tafasitamab-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","BK4532","BK4588","BK4550","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643247459","title":"Mirum, Incyte report pivotal Phase 2 PROGRESS data showing zilurgisertib cuts new FOP bone lesion volume 99.9% at Week 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2643247459","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643247459?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:35","pubTimestamp":1781469318,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals disclosed pivotal Phase 2 PROGRESS Cohort 1 results for oral ALK2 inhibitor zilurgisertib in FOP, already presented at ENDO 2026.The trial showed fewer new bone lesions and less overall disease progression on treatment versus placebo, with benefits sustained through 48 weeks.Patients who switched from placebo to zilurgisertib in the extension also showed no new lesions, supporting durability and crossover benefit.The FDA accepted an NDA for patients aged 12 and older with Priority Review, setting a PDUFA target action date of September 26, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on June 14, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nNDL28XmZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4532","BK4588","MIRM","BK4550","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643455247","title":"Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results From Progress Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2643455247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643455247?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:35","pubTimestamp":1781469300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nTUA8VC1DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","MIRM","BK4532","BK4585","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643121392","title":"Incyte says mutant CALR antibody INCA033989 delivers sustained responses in Phase 1 myelofibrosis, essential thrombocythemia studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2643121392","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643121392?lang=en_us&edition=fundamental","pubTime":"2026-06-13 23:15","pubTimestamp":1781363722,"startTime":"0","endTime":"0","summary":"Incyte says mutant CALR antibody INCA033989 delivers sustained responses in Phase 1 myelofibrosis, essential thrombocythemia studies. Incyte released updated Phase 1 data at EHA 2026 for INCA033989, a mutant CALR-targeted antibody in myelofibrosis and essential thrombocythemia.Trials showed rapid, durable clinical improvements across key disease measures, with molecular responses that supported a potential disease-modifying profile.Safety was described as manageable, with most patients remaining on therapy across both studies.A pivotal Phase 3 study in essential thrombocythemia is set to start in mid-2026, with regulators engaged on a pivotal myelofibrosis program.The FDA granted Breakthrough Therapy designation in November 2025 for Type 1 CALR-mutated essential thrombocythemia after prior cytoreductive therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDLbjQBXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","INCY","BK4532","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643321213","title":"Incyte Announces New Positive Data at Eha 2026 Showed Inca033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients With Myelofibrosis and Essential Thrombocythemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2643321213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643321213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 23:15","pubTimestamp":1781363701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nTUA9DRCRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4532","BK4588","BK4550","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643214863","title":"Incyte says Phase 3 frontMIND trial shows tafasitamab combo cuts lymphoma progression or death risk 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643214863","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643214863?lang=en_us&edition=fundamental","pubTime":"2026-06-13 18:00","pubTimestamp":1781344818,"startTime":"0","endTime":"0","summary":"Incyte disclosed pivotal Phase 3 frontMIND results, already presented at EHA 2026 and recently published.The tafasitamab-lenalidomide add-on to R-CHOP improved disease control in first-line high-risk DLBCL or HGBL versus standard R-CHOP.Findings supported a favorable trend in survival, though the survival readout remained inconclusive at this analysis.Safety was broadly consistent with expectations, with more severe side effects but similar treatment discontinuation rates versus R-CHOP.Data set up global regulatory filings for the regimen in previously untreated DLBCL or HGBL.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire  on June 13, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDLbSpQkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4532","BK4550","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643214868","title":"Results From Incyte’s Pivotal Phase 3 Frontmind Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (Eha) Congress Plenary Showed Prolonged Progression Free Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2643214868","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643214868?lang=en_us&edition=fundamental","pubTime":"2026-06-13 18:00","pubTimestamp":1781344800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nTUA8XDRXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4550","INCY","BK4139","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}